Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Mukherji, Agnibh [VerfasserIn]   i
 Ansari, Uzair [VerfasserIn]   i
 Borggrefe, Martin [VerfasserIn]   i
 Akın, Ibrahim [VerfasserIn]   i
 Behnes, Michael [VerfasserIn]   i
Titel:Clinically relevant biomarkers in acute heart failure
Titelzusatz:an update
Verf.angabe:Agnibh Mukherji, Uzair Ansari, Martin Borggrefe, Ibrahim Akin and Michael Behnes
Jahr:2017
Umfang:9 S.
Fussnoten:Gesehen am 25.04.2018
Titel Quelle:Enthalten in: Current pharmaceutical biotechnology
Ort Quelle:Hilversum : Bentham Science Publ., 2000
Jahr Quelle:2017
Band/Heft Quelle:18(2017), 6, Seite 482-490
ISSN Quelle:1873-4316
Abstract:Background: Acute Heart Failure (AHF), owing to the difficulties in diagnosis, prognostic stratification and patient-related management, is still associated with unusually high morbidity and mortality. The advent of novel biomarkers apart from natriuretic peptides involved in myocardial injury, neuro-hormonal activation, and ventricular remodeling augurs immense hope in redefining the biomarker-based approach towards AHF. Methods: A thorough review of the available literature including latest review articles from distinguished experts, textbook references and guidelines from leading cardiological societies worldwide as well as the latest trials, encompassing various biomarkers known in AHF was conducted. The most relevant ones were chosen as references for the current review article. Results: Biomarkers such as midregional proatrial natriuretic peptide, soluble ST2, highly-sensitive troponin, and midregional proadrenomedullin are some such examples that have passed various stages of substantiation while there is an array of potential biomarkers innascent stages like osteopontin, CTGF, GDF-15 and TGF beta-1 awaiting further reiteration. Not only the diagnosis of AHF itself but the evaluation of co-morbidities using markers like PCT, hematologic markers or acute kidney injury markers like NGAL present a new perspective to the management of AHF. Conclusion: This review article outlines the current status of the most relevant cardiac biomarkers related to AHF.
DOI:doi:10.2174/1389201018666170623090817
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: http://dx.doi.org/10.2174/1389201018666170623090817
 Volltext: http://www.eurekaselect.com.ezproxy.medma.uni-heidelberg.de/153563/article
 DOI: https://doi.org/10.2174/1389201018666170623090817
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1572367253
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68246653   QR-Code
zum Seitenanfang